Sales of orphan drugs
Rare diseases, also known as orphan diseases, are a group of various conditions characterized by their low prevalence in the population. Although each individual rare disease may be uncommon, collectively they have a significant impact on public health as they affect a large number of people worldwide.
Providing assistance to the population suffering from rare diseases requires joint efforts from various sectors of society and the international community. It is important to continue working on the development and implementation of effective strategies and measures aimed at improving the accessibility of medical care and the quality of life for patients with rare diseases.
In its distribution activities, “OAD-27” specializes in supplying orphan drugs for the treatment of rare diseases. The company holds a direct contract with the manufacturer of orphan drugs, enabling the provision of patients with original and high-quality orphan drugs. The supply of orphan drugs is a complex, multi-stage process that requires compliance with special storage and transportation conditions, as well as control of drug delivery to each patient.
“OAD-27” has great experience in supplying orphan drugs and possesses the necessary knowledge and resources to ensure their proper storage and transportation. We provide patients with consultations on the use of orphan drugs and offer them the necessary support. One of our main goals is to make orphan drugs accessible to all patients in need.
Our team actively participates in educational programs and events aimed at raising awareness about rare diseases and orphan drugs, and collaborates with charitable organizations that support patients with rare diseases. Our partners are provided with full marketing support, including market assessment, registration process, and distribution planning.
